Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/535,474external-prioritypatent/US4521421A/en
Priority claimed from US06/535,503external-prioritypatent/US4501890A/en
Priority claimed from US06/575,126external-prioritypatent/US4528290A/en
Priority claimed from FI843282Aexternal-prioritypatent/FI78091C/fi
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of FI882658A0publicationCriticalpatent/FI882658A0/fi
Publication of FI882658ApublicationCriticalpatent/FI882658A/fi
Publication of FI80679BpublicationCriticalpatent/FI80679B/fi
Application grantedgrantedCritical
Publication of FI80679CpublicationCriticalpatent/FI80679C/fi
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
FI882658A1983-09-261988-06-06Trans-( )-1-(alkyl eller allyl)-6-oxo- 7-alkoxikarbonyldekahydrokinoliner som aer anvaendbara som mellanprodukter vid framstaellning av som dopaminagonister anvaendbara pyrimido/4,5-g/ kinoliner.
FI80679C
(fi)
Trans-( )-1-(alkyl eller allyl)-6-oxo- 7-alkoxikarbonyldekahydrokinoliner som aer anvaendbara som mellanprodukter vid framstaellning av som dopaminagonister anvaendbara pyrimido/4,5-g/ kinoliner.
1-cyklopropyl-6-fluor-1,4-dihydro-4- oxo-7-(alkyl)- 1-piperazinyl)-3-kinolinkarboxylsyror, foerfarande foer deras framstaellning och dessa innehaollande antibakteriella produkter.
1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(4-(oxoalkyl)-1-piperazinyl)-3-quinolincarboxylsyre og derivater deraf,fremgangsmader til fremstilling deraf samt antibakterielle midler med indhold af disse forbindelser